KZIA
Kazia Therapeutics
KZIA
KZIA
7 hedge funds and large institutions have $269K invested in Kazia Therapeutics in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.
Holders
7
Holders Change
+2
Holders Change %
+40%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$146K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$10K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $146K | 46,001 | +6,501 | +16% |
|
2
Renaissance Technologies
New York
| $109K | 34,325 | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $10K | 3,053 | +1,013 | +50% |
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| $4K | 1,250 | – | – |
|
5
Bank of America
Charlotte,
North Carolina
| $0 | 5 | -196 | -98% |
|
|
AF
6
Advisornet Financial
Minnetonka,
Minnesota
| $0 | 5 | +5 | New |
|
|
SM
7
Sabby Management
Miami Beach,
Florida
| $0 | 366,668 | +366,668 | New |
|